These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17849641)

  • 21. Emerging issues in paediatric health research consent forms in Canada: working towards best practices.
    Dove ES; Avard D; Black L; Knoppers BM
    BMC Med Ethics; 2013 Jan; 14():5. PubMed ID: 23363554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What Is "Key Information"? Consideration of the Reasons People Do or Do Not Take Part in Research.
    Berwanger K; Merz JF
    Ethics Hum Res; 2024; 46(3):26-33. PubMed ID: 38629224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal-risk waiver of informed consent and exception from informed consent (Final Rule) studies at institutional review boards nationwide.
    Ernst AA; Weiss SJ; Nick TG; Iserson K; Biros MH
    Acad Emerg Med; 2005 Nov; 12(11):1134-7. PubMed ID: 16264084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Informed consent for research and authorization under the Health Insurance Portability and Accountability Act Privacy Rule: an integrated approach.
    Shalowitz D; Wendler D
    Ann Intern Med; 2006 May; 144(9):685-8. PubMed ID: 16670138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beyond Nazi War Crimes Experiments: The Voluntary Consent Requirement of the Nuremberg Code at 70.
    Annas GJ
    Am J Public Health; 2018 Jan; 108(1):42-46. PubMed ID: 29161060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of Common Rule Changes to the Informed Consent Form: A Research Staff and Institutional Review Board Collaboration.
    Gartel G; Scuderi H; Servay C
    Ochsner J; 2020; 20(1):76-80. PubMed ID: 32284686
    [No Abstract]   [Full Text] [Related]  

  • 27. How closely do institutional review boards follow the common rule?
    Lidz CW; Appelbaum PS; Arnold R; Candilis P; Gardner W; Myers S; Simon L
    Acad Med; 2012 Jul; 87(7):969-74. PubMed ID: 22622205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of the Revised Common Rule for Human Participant Research.
    DeRenzo EG; Moss J; Singer EA
    Chest; 2019 Feb; 155(2):272-278. PubMed ID: 30312589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inconsistency and institutional review boards.
    Goldman J; Katz MD
    JAMA; 1982 Jul; 248(2):197-202. PubMed ID: 7045428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the remedy: the case for contracts in clinical trials.
    Edwards SJ
    Am J Bioeth; 2011 Apr; 11(4):3-12. PubMed ID: 21480063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variations in institutional review board reviews of a multi-center, Emergency Department (ED)-based genetic research protocol.
    Lee DC; Peak DA; Jones JS; Domeier RM; Hendry PL; Rathlev NK; Swor RA; McLean SA
    Am J Emerg Med; 2013 Jun; 31(6):967-9. PubMed ID: 23623236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reaping the Bounty of Publicly Available Clinical Trial Consent Forms.
    Lynch HF; Largent EA; Zarin DA
    IRB; 2017; 39(6):10-15. PubMed ID: 29881132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the quality of information about alternatives to research participation in oncology consent forms.
    Resnik DB; Patrone D; Peddada S
    Contemp Clin Trials; 2010 Jan; 31(1):18-21. PubMed ID: 19897054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obtaining subjects' consent to publish identifying personal information: current practices and identifying potential issues.
    Yoshida A; Dowa Y; Murakami H; Kosugi S
    BMC Med Ethics; 2013 Nov; 14():47. PubMed ID: 24267590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of altered informed consent in pragmatic clinical research.
    McKinney RE; Beskow LM; Ford DE; Lantos JD; McCall J; Patrick-Lake B; Pletcher MJ; Rath B; Schmidt H; Weinfurt K
    Clin Trials; 2015 Oct; 12(5):494-502. PubMed ID: 26374677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Informed consent for research on stored blood and tissue samples: a survey of institutional review board practices.
    White MT; Gamm J
    Account Res; 2002; 9(1):1-16. PubMed ID: 12705242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excluding particular information from consent forms.
    Dickert N; Kass N; Paasche-Orlow M; Taylor H
    Account Res; 2005; 12(1):33-45. PubMed ID: 16021790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inalienable right to withdraw from research.
    McConnell T
    J Law Med Ethics; 2010; 38(4):840-6. PubMed ID: 21105947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current issues in clinical research and the development of new pharmaceuticals.
    Goldhammer A
    Account Res; 2001; 8(4):283-91. PubMed ID: 12481798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consent form heterogeneity in cancer trials: the cooperative group and institutional review board gap.
    Koyfman SA; Agre P; Carlisle R; Classen L; Cheatham C; Finley JP; Kuhrik N; Kuhrik M; Mangskau TK; O'Neill J; Reddy CP; Kodish E; McCabe MS
    J Natl Cancer Inst; 2013 Jul; 105(13):947-53. PubMed ID: 23821757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.